Post-transplant Cyclophosphamide and Tacrolimus for GVHD Prevention Allo-HCT from HLA-Matched Donors Generates more Advantages than Limitations TRANSPL CELL THER
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee EClinicalMedicine
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia ANN ONCOL